merck glp 1 agonist GLP-1 Receptor Market Size, Trends and Share Report 2026 merck glp 1 agonist Merck

This action helps in reducing appetite and can help promote significant weight loss as a result

Sitagliptin was approved in 2006, but in contrast to the GLP-1 agonists, DPP4 inhibitors have little or no effect on body weight

ChenWRHuSYChenYDZhangYQianGWangJet alEffects of liraglutide on left ventricular function in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

Exploring the Role of GLP-1 Receptor Agonists in Alzheimers Disease: A Review of Preclinical and Clinical Evidence

The hippocampus is recently reported to be at the center of the GLP-1 pathway network

ELIXA trial included patients with recent cardiovascular event (patients with acute coronary syndrome 180 days before randomization), and although there was no benefit in MACE reduction in lixisenatide treated patients compared to placebo, results revealed cardiovascular safety of lixisenatide in this specific high risk population (38, 40)